Home Gonadal function of beta-thalassemics following stem cell transplantation conditioned with myeloablative and reduced intensity regimens
Article
Licensed
Unlicensed Requires Authentication

Gonadal function of beta-thalassemics following stem cell transplantation conditioned with myeloablative and reduced intensity regimens

  • Preamrudee Poomthavorn EMAIL logo , Pongpan Chawalitdamrong , Suradej Hongeng , Pat Mahachoklertwattana , Samart Pakakasama , Patcharin Khlairit and La-or Chailurkit
Published/Copyright: May 24, 2013

Abstract

Gonadal dysfunction is a complication following stem cell transplantation (SCT). There have been no reports of gonadal function in stem-cell-transplanted thalassemic survivors who received a reduced intensity conditioning regimen (RIC). We evaluated gonadal function in 47 β-thalassemic patients following SCT with either myeloablative or reduced intensity regimen. Thirty-six patients received a myeloablative regimen, the remaining 11 patients had an RIC regimen. Their median (range) age was 13.2 (5.9–25.8) years. There were 29 patients (62%) with gonadal dysfunction (26 with primary gonadal dysfunction and three with gonadotropin deficiency). Comparisons between patients who received myeloablative and RIC regimens, revealed no differences in gonadal dysfunction (56% vs. 82%, p=0.113, respectively). In conclusion, our study demonstrated high frequency of gonadal dysfunction in these patients. Even after receiving RIC, gonadal dysfunction was very common. To our knowledge, this study is the first to report gonadal function in children and adolescents with β-thalassemia disease who were pre-transplanted with RIC.


Corresponding author: Preamrudee Poomthavorn, MD, Faculty of Medicine Ramathibodi Hospital, Department of Pediatrics, Mahidol University, Bangkok 10400 Thailand, Phone: +662 201-1394, Fax: +662 201-1850, E-mail:

This study was supported by a Research Grant from the Faculty of Medicine Ramathibodi Hospital, Mahidol University.

Conflict of interest statement

Financial disclosure: None.

References

1. Lucarelli G, Galimberti M, Delfini C, Agostinelli F, Giorgi C, et al. Marrow transplantation for thalassaemia following busulphan and cyclophosphamide. Lancet 1985;325:1355–7.10.1016/S0140-6736(85)91784-2Search in Google Scholar

2. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990;322:417–21.10.1056/NEJM199002153220701Search in Google Scholar

3. Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004;104:1201–3.10.1182/blood-2003-08-2800Search in Google Scholar

4. Vergauwen P, Ferster A, Valsamis J, Chanoine JP. Primary ovarian failure after prepubertal marrow transplant in a girl. Lancet 1994;343:125–6.10.1016/S0140-6736(94)90860-5Search in Google Scholar

5. Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22: 989–94.10.1038/sj.bmt.1701483Search in Google Scholar

6. Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, et al. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant 2004;33:1049–56.10.1038/sj.bmt.1704481Search in Google Scholar

7. Sarafoglou K, Boulad F, Gillio A, Sklar C. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr 1997;130:210–6.10.1016/S0022-3476(97)70345-7Search in Google Scholar

8. Sanders JE, Buckner CD, Leonard JM, Sullivan KM, Witherspoon RP, et al. Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 1983;36:252–5.10.1097/00007890-198309000-00005Search in Google Scholar

9. Al Jefri AH. Advances in allogeneic stem cell transplantation for hemoglobinopathies. Hemoglobin 2011;35:469–75.10.3109/03630269.2011.618567Search in Google Scholar

10. Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant 2003;9:519–28.10.1016/S1083-8791(03)00192-7Search in Google Scholar

11. Department of Health. Reference for weight, height and nutritional indices in Thais aged 1 day to 19 years. Bangkok, Thailand: Ministry of Public Health, 2000.Search in Google Scholar

12. World Health Organization. WHO growth reference data for 5–19 years. WHO Reference 2007. Available at: http://www.who.int/growthref/en/. Last accessed 2 May 2013.Search in Google Scholar

13. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.10.1136/adc.44.235.291Search in Google Scholar PubMed PubMed Central

14. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.10.1136/adc.45.239.13Search in Google Scholar PubMed PubMed Central

15. Poomthavorn P, Khlairit P, Mahachoklertwattana P. Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty. Horm Res 2009;72:114–9.10.1159/000232164Search in Google Scholar PubMed

16. Segal TY, Mehta A, Anazodo A, Hindmarsh PC, Dattani MT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab 2009;94:780–5.10.1210/jc.2008-0302Search in Google Scholar PubMed

17. Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant 2001;28:67–75.10.1038/sj.bmt.1703089Search in Google Scholar PubMed

18. Braunstein GD. Testes. In: Gardner DG, Shoback D, editors. Greenspan’s basic and clinical endocrinology. 8th ed. New York: McGraw-Hill, 2007:470–501.Search in Google Scholar

19. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, et al. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol 2002;56:215–21.10.1046/j.0300-0664.2001.01448.xSearch in Google Scholar PubMed

20. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, et al. Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol. Clin Endocrinol 2002;56:223–30.10.1046/j.0300-0664.2001.01449.xSearch in Google Scholar PubMed

21. Vlachopapadopoulou E, Kitra V, Peristeri J, Goussetis E, Karachaliou F, et al. Gonadal function of young patients with beta-thalassemia following bone marrow transplantation. J Pediatr Endocrinol Metab 2005;18:477–83.10.1515/JPEM.2005.18.5.477Search in Google Scholar PubMed

22. De Sanctis V, Galimberti M, Lucarelli G, Polchi P, Ruggiero L, et al. Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child 1991;66: 517–20.10.1136/adc.66.4.517Search in Google Scholar PubMed PubMed Central

23. De Sanctis V, Galimberti M, Lucarelli G, Angelucci E, Ughi M, et al. Gonadal function in long term survivors with beta-thalassemia major following bone marrow transplantation. Bone Marrow Transplant 1993;12(Suppl 1):104.Search in Google Scholar

24. Al-Rimawi HS, Jallad MF, Amarin ZO, Obeidat BR. Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major. Int J Gynaecol Obstet 2005;90:44–7.10.1016/j.ijgo.2005.03.024Search in Google Scholar PubMed

25. Roth C, Pekrun A, Bartz M, Jarry H, Eber S, et al. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion. Eur J Pediatr 1997;156:777–83.10.1007/s004310050711Search in Google Scholar PubMed

26. Safarinejad MR. Evaluation of semen quality, endocrine profile and hypothalamus-pituitary-testis axis in male patients with homozygous beta-thalassemia major. J Urol 2008;179:2327–32.10.1016/j.juro.2008.01.103Search in Google Scholar PubMed

27. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 2002;58(Suppl 1):72–9.10.1159/000064766Search in Google Scholar PubMed

28. Protonotariou AA, Tolis GJ. Reproductive health in female patients with beta-thalassemia major. Ann N Y Acad Sci 2000;900:119–24.Search in Google Scholar

29. Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update 2001;7:363–9.10.1093/humupd/7.4.363Search in Google Scholar PubMed

30. De Sanctis V, Galimberti M, Lucarelli G, Angelucci E, Ughi M, et al. Pubertal development in thalassaemic patients after allogenic bone marrow transplantation. Eur J Pediatr 1993;152:993–7.10.1007/BF01957223Search in Google Scholar PubMed

31. Li CK, Chik KW, Wong GW, Cheng PS, Lee V, et al. Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol 2004;21: 411–9.10.1080/08880010490457132Search in Google Scholar PubMed

32. Bath LE, Wallace WH, Shaw MP, Fitzpatrick C, Anderson RA. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18: 2368–74.10.1093/humrep/deg473Search in Google Scholar PubMed

33. Morita Y, Tilly JL. Oocyte apoptosis: like sand through an hourglass. Dev Biol 1999;213:1–17.10.1006/dbio.1999.9344Search in Google Scholar PubMed

34. Rivkees SA, Crawford JD. The relationship of gonadal activity and chemotherapy-induced gonadal damage. J Am Med Assoc 1988;259:2123–5.10.1001/jama.1988.03720140043031Search in Google Scholar

Received: 2012-12-12
Accepted: 2013-4-18
Published Online: 2013-05-24
Published in Print: 2013-10-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Review article
  4. Tamoxifen therapy for the management of pubertal gynecomastia: a systematic review
  5. Images in pediatric endocrinology
  6. Solitary median maxillary central incisor, a clinical predictor of hypoplastic anterior pituitary, ectopic neurohypophysis and growth hormone deficiency
  7. A rare case of granuloma annulare in a 6-year-old child with type 1 diabetes
  8. Original articles
  9. The arginine stimulation test: timing of peak is not a helpful parameter in the diagnosis of growth hormone deficiency
  10. The relationship between adiposity and stature in prepubertal children with celiac disease
  11. Influence of micronutrient status and socioeconomic gradient on growth indices of 2–18-year-old Indian girls
  12. Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature
  13. The relation between salivary cortisol and the metabolic syndrome score in girls
  14. Association of vitamin D concentrations with adiposity indices among preadolescent children in Korea
  15. Association of serum resistin levels with metabolic syndrome and early atherosclerosis in obese Chinese children
  16. Characteristics of infants at risk of hypoglycaemia secondary to being ‘infant of a diabetic mother’
  17. Parental dyadic coping in families of children and adolescents with type 1 diabetes
  18. Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome
  19. Effect of insulin therapy on IGF-1 level in children with new-onset type 1 diabetes mellitus: a comparison between DKA and non-DKA
  20. Mutation analysis of the SRD5A2, AR and SF-1 genes in 52 Chinese boys with hypospadias
  21. Sexual development in prepubertal obese boys: a 4-year longitudinal study
  22. Genetic diagnosis of one family with incomplete clinical data
  23. Patient reports
  24. Complete androgen insensitivity syndrome and discordant Müllerian remnants: two cases with novel mutation in the androgen receptor
  25. Psychosexual outcomes in three siblings with partial androgen insensitivity syndrome: impact of nature versus nurture
  26. Ambiguous genitalia in a 48, XXYY newborn: a casual relationship or a coincidence?
  27. Gonadal function of beta-thalassemics following stem cell transplantation conditioned with myeloablative and reduced intensity regimens
  28. Significant testicular enlargement in a 6.5-year-old boy with monorchism and testicular microlithiasis
  29. Report of the first case of precocious puberty in Rett syndrome
  30. Type II vitamin D-dependent rickets with diabetic ketoacidosis
  31. Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent
  32. A rare association between Rathke’s cyst and hypophysitis in a patient with delayed sex development and growth failure
  33. Diabetes mellitus with Laron syndrome: case report
  34. Wegener granulomatosis as an uncommon cause of panhypopituitarism in childhood
  35. Rare cases of autoimmune hypothyroidism in young children
  36. Cushing syndrome related to leukemic infiltration of the central nervous system: a case report and a possible role of LIF
  37. Early presentation of bilateral gonadoblastomas in a Denys-Drash syndrome patient: a cautionary tale for prophylactic gonadectomy
  38. Identification of a novel homozygous mutation (S144I) in a Malay patient with maple syrup urine disease
  39. Virilization in two pre-pubertal children exposed to topical androgen
  40. A family with Camurati-Engelman disease. The role of the missense p.R218C mutation in TGFB1 in bones and endocrine glands
  41. Short communications
  42. Plasma ceramides are elevated in female children and adolescents with type 2 diabetes
  43. Assessment of contractility and myocardial function in small and appropriate for gestational age premature neonates using the stress-velocity relationship and tissue Doppler imaging immediately after birth
  44. Letter to the Editors
  45. Homeostasis model assessment of insulin resistance may not be reliable to evaluate insulin sensitivity in young obese children
  46. Type 1 diabetes in women with endometriosis: what is the risk of occurrence?
  47. How should we manage vitamin D-deficient adolescents?
  48. Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically?a
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0399/html
Scroll to top button